Effect of Smoke Evacuator on Reduction of Volatile Organic Compounds and Particles in Surgical Smoke: A Randomized Controlled Trial.


Journal

Journal of the American College of Surgeons
ISSN: 1879-1190
Titre abrégé: J Am Coll Surg
Pays: United States
ID NLM: 9431305

Informations de publication

Date de publication:
08 Dec 2023
Historique:
medline: 8 12 2023
pubmed: 8 12 2023
entrez: 8 12 2023
Statut: aheadofprint

Résumé

Surgical smoke is an occupational health problem and is increasingly recognized as a potential source of virus transmission. Dedicated smoke evacuators are used to protect against surgical smoke exposure. We tested the hypothesis that using smoke evacuators would reduce volatile organic compounds (VOCs) and the number of particles in surgical smoke during the laparotomy procedure. A randomized, double-blind clinical trial was conducted in patients undergoing laparotomy from June 11, 2021, to March 30, 2022, to compare the effectiveness of smoke evacuators with a control (registration, UMIN000044250). The primary outcome was a change in the acetaldehyde level. Secondary outcomes were changes in the formaldehyde level and particle count assessed by the particle size of 0.3 nm, 0.5 nm, 1.0 nm, and 5.0 nm. A total of 42 patients were randomized and assessed (smoke evacuator group, n = 22 vs. control group, n = 20). The acetaldehyde level was significantly lower in smoke evacuator group than in control group: mean (95% confidence interval), 10.6 (3.7-17.5) μg/m 3 vs. 47.2 (19.9-74.5) μg/m 3, P < .001. Similarly, the formaldehyde level was 72.2% lower in smoke evacuator group than in control group. Particle counts by each particle size category were 80%-95% lower in smoke evacuator group than in control group (all, P < .001). Dedicated smoke evacuators reduced the level of acetaldehyde and formaldehyde, and the number of particles in surgical smoke, minimizing the potential exposure to VOCs and particle matters during surgery.

Sections du résumé

BACKGROUND BACKGROUND
Surgical smoke is an occupational health problem and is increasingly recognized as a potential source of virus transmission. Dedicated smoke evacuators are used to protect against surgical smoke exposure. We tested the hypothesis that using smoke evacuators would reduce volatile organic compounds (VOCs) and the number of particles in surgical smoke during the laparotomy procedure.
STUDY DESIGN METHODS
A randomized, double-blind clinical trial was conducted in patients undergoing laparotomy from June 11, 2021, to March 30, 2022, to compare the effectiveness of smoke evacuators with a control (registration, UMIN000044250). The primary outcome was a change in the acetaldehyde level. Secondary outcomes were changes in the formaldehyde level and particle count assessed by the particle size of 0.3 nm, 0.5 nm, 1.0 nm, and 5.0 nm.
RESULTS RESULTS
A total of 42 patients were randomized and assessed (smoke evacuator group, n = 22 vs. control group, n = 20). The acetaldehyde level was significantly lower in smoke evacuator group than in control group: mean (95% confidence interval), 10.6 (3.7-17.5) μg/m 3 vs. 47.2 (19.9-74.5) μg/m 3, P < .001. Similarly, the formaldehyde level was 72.2% lower in smoke evacuator group than in control group. Particle counts by each particle size category were 80%-95% lower in smoke evacuator group than in control group (all, P < .001).
CONCLUSIONS CONCLUSIONS
Dedicated smoke evacuators reduced the level of acetaldehyde and formaldehyde, and the number of particles in surgical smoke, minimizing the potential exposure to VOCs and particle matters during surgery.

Identifiants

pubmed: 38063669
doi: 10.1097/XCS.0000000000000921
pii: 00019464-990000000-00792
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.

Auteurs

Yoshikuni Kawaguchi (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yuhi Yoshizaki (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Toshiaki Kawakami (T)

Environmental Technology Center co., Ltd., Saitama, Japan.

Mitsuru Iwamoto (M)

Environmental Technology Center co., Ltd., Saitama, Japan.

Tomoaki Hayakawa (T)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yoshihito Hayashi (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yui Sawa (Y)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kyoji Ito (K)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kosuke Kashiwabara (K)

Biostatistics Division, Central Coordinating Unit, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.

Nobuhisa Akamatsu (N)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Junichi Kaneko (J)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yasuyoshi Nishikata (Y)

Environmental Technology Center co., Ltd., Saitama, Japan.

Kiyoshi Hasegawa (K)

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Classifications MeSH